Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.40
Bid: 2.30
Ask: 2.50
Change: 0.00 (0.00%)
Spread: 0.20 (8.696%)
Open: 2.40
High: 2.40
Low: 2.40
Prev. Close: 2.40
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FundamentalVR Fund Raise

11 Aug 2022 14:05

RNS Number : 6261V
Tern PLC
11 August 2022
 

11 August 2022

 

Tern Plc

("Tern" or the "Company")

 

FundamentalVR Fund Raise

 

Further to the announcement dated 31 May 2022, Tern Plc (AIM:TERN), the company focused on value creation from Internet of Things ("IoT") technology businesses, is pleased to announce that FVRVS Limited ("FundamentalVR"), has closed a second tranche of its Series B fund raising round, securing an additional £5 million in new investment (the "FundamentalVR Series B second tranche") from a new institutional investor at the same valuation as the first tranche, which was an uplift of 35% from the previous book valuation of Tern's holding prior to the Series B fund raising.

 

Highlights

 

FundamentalVR has now raised a total of £13.2 million in Series B funding ("FundamentalVR Series B"), from a new institutional investor and its existing investors:

 

· As previously announced on 31 May 2022, Tern converted the £570,000 in loan notes and accrued interest it held in FundamentalVR into equity in the business and has not invested additional new money in this FundamentalVR Series B second tranche;

 

· The FundamentalVR Series B is intended to provide FundamentalVR with funding to enable the business to focus on accelerating its annual recurring revenue growth through the significant pipeline of opportunities it has, together with launching new data and analytical products, and establishing a US-based artificial intelligence innovation centre;

 

· Prior to the second tranche of the FundamentalVR Series B fund raise Tern held 20.0% of FundamentalVR's equity. With the completion of the £5 million FundamentalVR Series B second tranche, Tern will hold 16.58% of FundamentalVR's equity (before any dilution on exercise of any future FundamentalVR employee share options), valued at £4.8 million at the valuation implied by the FundamentalVR Series B funding round.

 

Commenting Al Sisto, CEO of Tern, said:

 

"We are delighted that FundamentalVR has secured the funding to take advantage of the significant market traction it has gained in the last eighteen months, particularly with growth in annual recurring revenues, and the opportunities it is seeing.

 

"Given our focus on funding and assisting the earlier stages of our company's development it is appropriate that we have not committed further capital at the Series B stage. However, with the funds raised we believe FundamentalVR has the potential to generate significant future value for Tern and its shareholders and we are delighted to continue to remain one of its largest shareholders.

 

"FundamentalVR provides Tern and its shareholders with exposure to the rapidly growing medical simulation market using low cost open-system IoT devices. It is quickly building its annual recurring revenues and the lifetime value of its contracts, and we believe that the business will be an attractive target for a trade buyer or for an IPO in due course. In the meantime, we look forward to continuing to participate in the value it is creating."

 

FundamentalVR Fund Raise

 

Prior to the FundamentalVR Series B Tern had a holding of 26.9% in FundamentalVR, plus a loan convertible into FundamentalVR equity of £530,000 and accrued interest of £39,932. As at 31 December 2021, the date of Tern's last published book valuation, this holding had an audited book value of £3.6 million. Including the convertible loan notes, Tern has invested £2.9 million in FundamentalVR since May 2018.

 

Following the two tranches of FundamentalVR Series B funding of £13.2 million, Tern now has a holding of 16.58% in FundamentalVR (before any dilution on exercise of any future FundamentalVR employee share options), with an unaudited book valuation of £4.8 million, representing a 35% uplift on the 31 December 2021 book value of Tern's holding and an uplift of 62% over the amount invested by Tern in FundamentalVR to date. The change in the valuation and uplift of £6.3 million and 77%, respectively, as disclosed in the announcement on 31 May 2022, has come to light as a result of the calculations relating to the new holding following the FundamentalVR Series B second tranche.

 

Further information on FundamentalVR

 

Since Tern's initial investment in FundamentalVR in May 2018 the business has focussed on the commercialisation of its haptics virtual reality simulation solutions, as a credible alternative to in-person and on human learning. The adoption of FundamentalVR's solutions accelerated as a result of the challenges of social distancing and the reduction in elective surgeries as a result of the Covid-19 pandemic and this trend is continuing. 

Today, FundamentalVR is the world's first scalable medical simulation platform to combine virtual reality and haptics through data, artificial intelligence, and multimodal learning. FundamentalVR's patented HapticVRTM technology mimics the physical touch of surgical actions which allows users to experience the sights, sounds, and physical sensations of real-life surgery. Scalable and hardware agnostic, the platform immerses users in a controlled training environment that lowers the surgical risk to patients.

Deployed in over 30 countries, FundamentalVR's high-fidelity simulations help life sciences, pharmaceutical, and med-device companies deploy medical innovations in disciplines from ophthalmology to robotics, gene therapy, and more. The growth investment will enable further development of HapticVRTM, the machine learning data insights product, and geographic expansion throughout the US. FundamentalVR's multiuser platform enables medical institutions, hospitals, and surgical educators, to scale professionally accredited surgical training throughout their organisations. Partnerships with hospital groups, including flagship clients and investors Mayo Clinic and Sana Kliniken, will help drive further growth. FundamentalVR has continued to trade strongly in the past year, with significant new business wins and long-term contracts secured.

Further information on FundamentalVR may be found at: https://www.fundamentalvr.com

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKKBPABKDDFD
Date   Source Headline
30th Nov 20113:57 pmRNSTotal Voting Rights
10th Nov 20117:00 amRNSOperations Update
4th Nov 20117:00 amRNSIssue of Equity
31st Oct 20116:11 pmRNSTotal Voting Rights
21st Oct 20117:00 amRNSWarrant Exercise, Placing and Director's Dealing
18th Oct 20117:00 amRNSIssue of Equity
3rd Oct 201111:27 amRNSHolding(s) in Company
29th Sep 20117:00 amRNSDirector Dealing and Warrant Exercise
27th Sep 201112:25 pmRNSInterim Results
20th Sep 201110:27 amRNSMajor Interest in Shares
6th Sep 20117:00 amRNSOperations Update
31st Aug 20118:00 amRNSAIM Admission and Directorate Changes
30th Aug 201111:59 amRNSResult of GM
25th Aug 20112:18 pmRNSSchedule 1 update - Silvermere Energy plc
25th Aug 201112:55 pmRNSAcquisition update
18th Aug 20112:19 pmRNSAdjourned General Meeting
18th Aug 201110:02 amRNSSchedule 1 update - Silvermere Energy plc
15th Aug 20117:00 amRNSAcquisition Update
5th Aug 20117:00 amRNSChange of Website Address
4th Aug 20115:05 pmRNSSch 1 - Silvermere Energy plc
2nd Aug 20111:45 pmRNSProposed Placing and Acquisition of Mustang Asset
14th Jul 20114:18 pmRNSResult of AGM and Change of Name
13th Jul 20117:00 amRNSCorrection - Issue of Loan Notes
4th Jul 20117:00 amRNSFundraise and Further Loan to Core
20th Jun 20113:23 pmRNSFinal Results
15th Jun 201112:30 pmRNSChange of Registered Office
15th Jun 201111:30 amRNSLoan to Core Oil & Gas and Company appointments
26th May 20119:58 amRNSSubscription to raise £1m and discussions update
16th May 20111:30 pmRNSUpdate on Discussions with Core Oil & Gas Inc.
17th Mar 201110:53 amRNSUpdate on Discussions with Core Oil & Gas Inc.
28th Feb 201110:30 amRNSTotal Voting Rights
22nd Feb 20112:20 pmRNSAppointment of Joint Broker
16th Feb 20117:00 amRNSInterim Results
14th Feb 201110:57 amRNSChange of Registered Office
11th Feb 20113:53 pmRNSHolding(s) in Company
7th Feb 20114:45 pmRNSFurther Loan to Core Oil & Gas Inc.
26th Jan 20117:30 amRNSSubscription, Suspension and Board Changes
19th Jan 20112:30 pmRNSHolding(s) in Company
23rd Dec 20103:43 pmRNSResignation of Adviser - Replacement
8th Dec 201011:29 amRNSResignation of Adviser
6th Dec 201010:45 amRNSTotal Voting Rights - Correction
2nd Dec 20109:50 amRNSDirectorate Change
29th Nov 201012:34 pmRNSResult of AGM
4th Nov 20104:13 pmRNSTotal Voting Rights
4th Nov 20107:00 amRNSFinal Results
1st Nov 20107:00 amRNSIssue of Equity, Granting of Loan, Changes in Shar
1st Nov 20107:00 amRNSExpected Agreement & Fundraising
24th Mar 20109:30 amRNSSuspension - The Core Business plc
24th Mar 20107:00 amRNSRestoration - Core Business plc
25th Sep 20093:00 pmRNSSuspension - Core Business Plc (The)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.